PRQR Jun 2024 2.500 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.8500

0.0000

(0.00%)

As of 10:25AM EDT. Market open.

Simply Wall St.
Institutions own 25% of ProQR Therapeutics N.V. (NASDAQ:PRQR) shares but retail investors control 46% of the company
Key Insights ProQR Therapeutics' significant retail investors ownership suggests that the key decisions are influenced...
GlobeNewswire
ProQR Announces Presentation on its Axiomer™ RNA Editing Technology at RNA Editing Summit
LEIDEN, Netherlands & CAMBRIDGE, Mass., June 18, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it will participate in the RNA Editing Summit, June 18-20, 2024, in Boston, Massachusetts. As part of the conference program, Gerard Platenburg, Chief Scientific Officer and Co-Founder, ProQR Therapeutics, will present on June 20, 2024 at 2:00pm ET: “Developing Axiomer RNA Editing Techno
Simply Wall St.
Shareholders in ProQR Therapeutics (NASDAQ:PRQR) are in the red if they invested five years ago
Long term investing works well, but it doesn't always work for each individual stock. We don't wish catastrophic...